W Advisors LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$490K Sell
533
-10
-2% -$10.1K 0.25% 79
2025
Q4
$584K Hold
543
0.29% 72
2025
Q3
$414K Hold
543
0.22% 90
2025
Q2
$423K Buy
543
+3
+0.6% +$2.33K 0.24% 80
2025
Q1
$446K Hold
540
0.28% 78
2024
Q4
$417K Sell
540
-2
-0.4% -$1.66K 0.26% 78
2024
Q3
$480K Sell
542
-3
-0.6% -$2.7K 0.3% 67
2024
Q2
$493K Buy
545
+3
+0.6% +$2.4K 0.32% 66
2024
Q1
$422K Buy
542
+3
+0.6% +$2.13K 0.29% 68
2023
Q4
$314K Sell
539
-4
-0.7% -$2.33K 0.23% 83
2023
Q3
$292K Sell
543
-6
-1% -$3.09K 0.24% 84
2023
Q2
$257K Buy
+549
New +$230K 0.2% 89
2023
Q1
Sell
-557
Closed -$204K 107
2022
Q4
$204K Buy
+557
New +$197K 0.17% 103

Other funds holding LLY

W Advisors LLC's LLY Position: Q1 2026 in Review

W Advisors LLC reduced its Eli Lilly (LLY) stake by 1.8% in Q1 2026, selling an estimated $10.1K and leaving 533 shares worth $490K. The position accounts for 0.25% of the portfolio, ranked #79.

W Advisors LLC first reported a position in LLY in Q4 2022 and has held it in 13 quarters since. The position peaked at $584K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • W Advisors LLC held 533 shares of Eli Lilly worth $490K as of Q1 2026.
  • W Advisors LLC sold 10 Eli Lilly shares in Q1 2026, an estimated $10.1K.
  • Eli Lilly made up 0.25% of W Advisors LLC's portfolio in Q1 2026, its #79 holding.
  • W Advisors LLC first reported a position in Eli Lilly in Q4 2022 and has held it in 13 quarters since.
  • W Advisors LLC's Eli Lilly position peaked at $584K in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on W Advisors LLC's 13F filing for Q1 2026, filed 29 Apr 2026.